Prospects for creating a vaccine against prostate cancer have already loomed on the horizon. British scientists have created a unique medicine that enhances the ability of the immune system to track and kill deadly cells as they appear.

One day, millions of men will have the opportunity to protect themselves from prostate cancer with a single injection. British scientists are developing a vaccine that can strengthen the ability of the immune system to track and destroy malignant cells as they appear in the body. Although the study is at an early stage, its authors at Queen's University in Belfast believe that the information they obtained can be used to vaccinate young men against prostate tumors. Moreover, the vaccine has the potential to become a powerful treatment for prostate cancer, as it teaches the body to kill tumors.

The new vaccine will use the RNA - a genetic transmitter, training the immune system to recognize prostate cancer cells and destroy them. In the laboratory, the unique drug has already confirmed its efficiency, and now three-year trials on laboratory mice begin, after which experiments with human participation should follow.

We note that scientists are developing RNA-based vaccines against prostate cancer for several years, but they all fail because there is no effective way of delivering these drugs to the immune system.

Part of this problem is due to ordinary injections of RNA into the bloodstream. But in the blood, the drugs dissolve rather quickly before they reach the immune cells. Researchers from Belfast think that they solved this problem at the expense of a new delivery mechanism by conducting a combination of RNA with sugar enzymes. This will allow the vaccine to survive in the body.

medinfo. ua.

Keywords:.